CardioCrown Explores Global Opportunities for Neurorehabilitation
Engaging Key Stakeholders in New York to Drive Wider Adoption of NeuroVive
News
CardioCrown Concludes Strategic Planning Phase with SBC Catalyzer
Charting a 17-Month Roadmap for NeuroVive’s Development and Commercialisation
Strengthening Ties: CardioCrown’s Impactful Engagement with the Irish MedTech Sector
Exploring New Opportunities through the Global Business Innovation Programme
CardioCrown Advances to Semifinals of Discovery Spark and Shines at GIANT Health
Paving the Way for Innovation in Healthcare: CardioCrown Excels at Discovery Spark and GIANT Health Event
Brunel’s Research, Innovate, and Emerge (RIEm) Program Empowers CardioCrown in HealthTech Innovation
RIEm Supports SMEs with Innovation Funding, Research Collaboration, and Strategic Guidance for Business Growth
CardioCrown Showcases Groundbreaking Stroke Rehabilitation Solution at BioSeed Summer Event 2024
Victor Harbari Highlights CardioCrown’s Innovative Approach and Opens New Investment Round at OBN’s Life Sciences Event
CardioCrown Welcomes Heraldas Gaspariunas as Chief Operations Officer
Life Science Leader Joins CardioCrown to Drive Growth and Innovation in MedTech
CardioCrown and Brunel University Drive Stroke Rehabilitation Innovation through Brunel Innovation Voucher Scheme
Collaborative Project Advances New Technologies for Stroke Survivors with Support from Brunel University and Local Clinicians
CardioCrown Joins Innovate UK’s Global Business Innovation Programme to Strengthen MedTech Opportunities in the Netherlands
UK Delegation Explores International Collaboration and Growth in Dutch MedTech Market
CardioCrown Awarded Innovate UK Grant to Advance NeuroVive Stroke Rehabilitation System
Funding to Drive Development of CardioCrown’s Innovative Home-Based Stroke Rehabilitation Technology